Illumina woes shine light on industry trouble
October 07, 2011 at 13:50 PM EDT
A revenue warning from biotechnology firm Illumina causes shares to tank — and takes a bite out of the market caps of other players in the industry.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.